Skip to main content
. Author manuscript; available in PMC: 2013 Sep 27.
Published in final edited form as: Xenotransplantation. 2011 Mar-Apr;18(2):121–130. doi: 10.1111/j.1399-3089.2011.00631.x

Fig. 4.

Fig. 4

Expression of human thrombomodulin (TBM) by COS-7 cells stably transfected with 4-gene construct #5 (CMV/Hygro-TBM-CTLA4Ig-CD39) after selection with neomycin (middle panel) or hygromycin (bottom panel). Control vectortransfected cells selected with neomycin are shown in the top panel. A representative example of two separate experiments is shown.